Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSPHENYTOIN vs FOSTAMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSPHENYTOIN vs FOSTAMATINIB: Safety Overview

Metric FOSPHENYTOIN FOSTAMATINIB
Total FAERS Reports 1,378 6,394
Deaths Reported 166 453
Death Rate 12.0% 7.1%
Hospitalizations 646 1,493
Average Patient Age 37.5 yrs 64.7 yrs
% Female Patients 52.4% 60.8%
FDA Approval Date Aug 5, 1996 Apr 17, 2018
Manufacturer Pfizer Laboratories Div Pfizer Inc Rigel Pharmaceuticals, Inc.
Route INTRAMUSCULAR ORAL
Marketing Status Prescription Prescription